Pershing Square Capital
View Older Stories View More Recent Stories
-
Pershing Square Valeant Pharma (VRX) Conf. Call Up and Running after Technical Difficulties
-
Valeant Pharma (VRX) on Watch as Ahead of Pershing Square Conference Call
-
Valeant says Philidor pharmacy shutting down as it cuts ties
-
Ackman's Pershing Square Down 15.9% YTD
-
ValueAct rallies Valeant investors as company fends off attack: source
-
Ackman to hold call to discuss investment in Valeant
-
Ackman's Pershing Square to Hold Conf. Call About Valeant Pharma (VRX) Investment
-
Valeant slump poses big threat to small hedge funds
-
Valeant vows to refute 'phantom sales' allegations
-
Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International
-
Pershing Square's Ackman Down ~40% on Valeant Pharma (VRX) Bet
-
UPDATE: Ackman Bought 2M More Shares of Valeant Pharma (VRX) - CNBC
-
Hedge Funds on Edge as Valeant Pharma (VRX) Sinks
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
Democrats take aim at drug prices, prompting sharp drops in biotech stocks
-
Hedge funds that crowded into same names likely to nurse losses
-
Ackman's hedge fund down 13.1 percent for August
-
Ackman says Pershing Square down for the year after markets drop
-
Pershing Square, ValueAct are Top Hedge Funds at Risk of 'Squeeze' Amid Market Volatility - Symmetric
-
Ackman's Pershing Square Liquidates Actavis Stake in Q2 - 13F
-
Highlights from Pershing Square's Q2 Conf. Call; Bought Mondelez (MDLZ) Hand-Over-Fist, Hasn't Engaged China About Herbalife (HLF)
-
Ackman's Pershing Square Boosts Zoetis (ZTS) Stake; Takes Positions in Actavis (ACT), Valeant (VRX) - 13F
-
Pershing Square up 6.3% through April - CNBC
-
Jarden (JAH) Undervalued, Says Ackman at Sohn
-
Valeant (VRX) vs. Allegan (AGN) Suit Dropped by All Parties
-
Market Wrap: Feb. Durable Orders Miss Expectations; Heinz, Kraft to Merge; Tesla Sinks on Two-Notch Downgrade
-
Zoetis (ZTS) Off Lows as Ackman to Discuss Acquisitions/JVs with Valeant (VRX)
-
Streetinsider.com's Hot Lunchtime Reads 3/26: (VRX) (CMCSA) (MU) (KRFT)
-
Pershing Square Files 13D on Valeant Pharma (VRX); May Conduct Talks with Management
-
Form SC 13D Valeant Pharmaceuticals Filed by: Pershing Square Capital Management, L.P.
-
Valeant Pharma (VRX) to Raise Salix Pharma (SLXP) Bid Above $160/Sh - NYT
-
Notable 52-Week Highs and Lows 3/9: (CRMD) (CY) (VRX) High; (LL) (ACRX) (ADAT) Low
-
Pershing Square Reports 4.9% Stake in Valeant Pharma (VRX)
-
Pershing Square Announces New Position in Valeant Pharmaceuticals International
-
Pershing Square buys 5% stake in Valeant Pharma (VRX) - Reuters
-
Ackman's Pershing Square Granted Early Antitrust Approval for Deal Involving Zoetis (ZTS)
-
Zoetis (ZTS) Abbott Deal Seen as 'Good', BMO Capital Says; Focus Remains on Takeover Prospects (VRX)
-
UPDATE: Actavis Plc (ACT) Said in Talks to Acquire Allergan (AGN) for $60B (VRX)
-
Zoetis (ZTS) Confirms Bill Ackman Call; No Comment on Details of Conversation
-
Zoetis (ZTS) Active: Pershing Square Takes Stake - DJ
-
Allergan (AGN): If Valeant (VRX) Increased Offer, Board Would Consider It
-
Ruling Allows Valeant (VRX), Pershing Square and Other Allergan (AGN) Shareholders to Vote at December 18 Special Meeting
-
Notable Mergers and Acquisitions of the Day 10/27: (WPZ)/(ACMP) (VRX)/(AGN) (HES) (CQB)
-
Valeant (VRX) Delivers Letter to Allergan (AGN) Board; Prepared to Boost Offer to $200/Share
-
Pre-Open Stock Movers 10/08: (GTAT) (UNIS) (CMRX) Higher; (TILE) (GPRO) (MON) Lower (more...)
-
After-Hours Stock Movers 10/07: (UNIS) (TST) (AGN) Higher; (TILE) (GPRO) (MG)
-
Valeant Pharma (VRX), Pershing Square plan to raise Allergan (AGN) bid by $15 per share - WSJ
-
Allergan (AGN) Files to Block Ackman's Pershing Square from Voting at Dec. Meeting (VRX)
-
Allergan (AGN) Responds to Recent Valeant (VRX) Publication
-
Allergan (AGN), Valeant (VRX), Pershing Square Enter Litigation Settlement; Special Meeting Date Set

